Cargando…
Cardiac Involvement of COVID-19: A Comprehensive Review
Coronavirus Disease 2019 (COVID-19) is an infectious disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus. SARS-CoV-2 caused COVID-19 has reached a pandemic level. COVID-19 can significantly affect patients’ cardiovascular systems. First, those with COVID-19 and preex...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Southern Society for Clinical Investigation. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536131/ https://www.ncbi.nlm.nih.gov/pubmed/33187633 http://dx.doi.org/10.1016/j.amjms.2020.10.002 |
_version_ | 1783590498437431296 |
---|---|
author | Chang, Wei-Ting Toh, Han Siong Liao, Chia-Te Yu, Wen-Liang |
author_facet | Chang, Wei-Ting Toh, Han Siong Liao, Chia-Te Yu, Wen-Liang |
author_sort | Chang, Wei-Ting |
collection | PubMed |
description | Coronavirus Disease 2019 (COVID-19) is an infectious disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus. SARS-CoV-2 caused COVID-19 has reached a pandemic level. COVID-19 can significantly affect patients’ cardiovascular systems. First, those with COVID-19 and preexisting cardiovascular disease have an increased risk of severe disease and death. Mortality from COVID-19 is strongly associated with cardiovascular disease, diabetes, and hypertension. Second, therapies under investigation for COVID-19 may have cardiovascular side effects of arrhythmia. Third, COVID-19 is associated with multiple direct and indirect cardiovascular complications. Associated with a high inflammatory burden related to cytokine release, COVID-19 can induce vascular inflammation, acute myocardial injury, myocarditis, arrhythmias, venous thromboembolism, metabolic syndrome and Kawasaki disease. Understanding the effects of COVID-19 on the cardiovascular system is essential for providing comprehensive medical care for cardiac and/or COVID-19 patients. We hereby review the literature on COVID-19 regarding cardiovascular virus involvement. |
format | Online Article Text |
id | pubmed-7536131 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Southern Society for Clinical Investigation. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75361312020-10-06 Cardiac Involvement of COVID-19: A Comprehensive Review Chang, Wei-Ting Toh, Han Siong Liao, Chia-Te Yu, Wen-Liang Am J Med Sci Review Article Coronavirus Disease 2019 (COVID-19) is an infectious disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus. SARS-CoV-2 caused COVID-19 has reached a pandemic level. COVID-19 can significantly affect patients’ cardiovascular systems. First, those with COVID-19 and preexisting cardiovascular disease have an increased risk of severe disease and death. Mortality from COVID-19 is strongly associated with cardiovascular disease, diabetes, and hypertension. Second, therapies under investigation for COVID-19 may have cardiovascular side effects of arrhythmia. Third, COVID-19 is associated with multiple direct and indirect cardiovascular complications. Associated with a high inflammatory burden related to cytokine release, COVID-19 can induce vascular inflammation, acute myocardial injury, myocarditis, arrhythmias, venous thromboembolism, metabolic syndrome and Kawasaki disease. Understanding the effects of COVID-19 on the cardiovascular system is essential for providing comprehensive medical care for cardiac and/or COVID-19 patients. We hereby review the literature on COVID-19 regarding cardiovascular virus involvement. Southern Society for Clinical Investigation. Published by Elsevier Inc. 2021-01 2020-10-06 /pmc/articles/PMC7536131/ /pubmed/33187633 http://dx.doi.org/10.1016/j.amjms.2020.10.002 Text en © 2020 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Review Article Chang, Wei-Ting Toh, Han Siong Liao, Chia-Te Yu, Wen-Liang Cardiac Involvement of COVID-19: A Comprehensive Review |
title | Cardiac Involvement of COVID-19: A Comprehensive Review |
title_full | Cardiac Involvement of COVID-19: A Comprehensive Review |
title_fullStr | Cardiac Involvement of COVID-19: A Comprehensive Review |
title_full_unstemmed | Cardiac Involvement of COVID-19: A Comprehensive Review |
title_short | Cardiac Involvement of COVID-19: A Comprehensive Review |
title_sort | cardiac involvement of covid-19: a comprehensive review |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536131/ https://www.ncbi.nlm.nih.gov/pubmed/33187633 http://dx.doi.org/10.1016/j.amjms.2020.10.002 |
work_keys_str_mv | AT changweiting cardiacinvolvementofcovid19acomprehensivereview AT tohhansiong cardiacinvolvementofcovid19acomprehensivereview AT liaochiate cardiacinvolvementofcovid19acomprehensivereview AT yuwenliang cardiacinvolvementofcovid19acomprehensivereview |